Last week, the California Institute for Regenerative Medicine (CIRM) approved a new funding program aimed at accelerating gene therapies for rare diseases by moving away from traditional approaches ...

Jonathan Thomas, PhD, JD has been appointed CIRM’s President and CEO · GlobeNewswire Inc. Jonathan Thomas, PhD, JD Jonathan Thomas, PhD, JD has been appointed CIRM’s President and CEO · GlobeNewswire ...

It must seem odd that someone who has spent countless hours over the last 15 years as a member of the governing board of the California Institute for Regenerative Medicine (CIRM) would oppose ...

AcuraStem, a biotechnology company advancing treatments for amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other neurodegenerative diseases, announced today that the ...

WOODBRIDGE, Conn.--(BUSINESS WIRE)--Cure Rare Disease (CRD) announced it has been awarded a $5.69 million grant from the California Institute for Regenerative Medicine (CIRM) to advance the ...

Institute also doled out its third Research Leadership award totaling $5.6 million. The California Institute for Regenerative Medicine (CIRM) reports that it has approved $27 million for two funds, ...

South San Francisco, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- The California Institute for Regenerative Medicine (CIRM) has approved a new funding program to accelerate therapies for rare diseases, ...

On Wednesday, the California Institute for Regenerative Medicine's governing committee voted unanimously to approve proposed guidelines for reducing conflicts of interest, U-T San Diego reports. CIRM ...

Re “Stem cell funding debate” (Sept. 26): Based solely on the arguments posed in the op-ed section, the winner, hands down in my opinion, is John Moorlach, who reasoned that very little in the way of ...

CIRM spokesperson Dale Carlson says that who is named as CIRM's next chief scientific officer will depend on who the agency selects as the next permanent president. Stay tuned to **__The Scientist__** ...